Literature DB >> 3877859

Yersinia enterocolitica infection in children.

D J Marriott, S Taylor, D C Dorman.   

Abstract

The role of Yersinia enterocolitica as a human pathogen has been documented in publications from over 30 countries, and Y. enterocolitica has been recognized increasingly to cause gastrointestinal disease in children. In 1979, an Australian survey yielded only three isolates of Y. enterocolitica from 3298 faecal specimens obtained from adults. We screened all stool specimens received during a 22-month period for Yersinia by means of a recently developed selective agar medium. Y. enterocolitica was isolated from 32 of 4136 (0.7%) specimens. Most isolates were of serotype O:3, biotype 4. During the study, 154 Salmonella spp. (3.7%), 196 Campylobacter spp. (47%), seven Shigella spp. (0.2%) and 27 Aeromonas spp. (0.9% of 2779) were recovered. Children infected with Y. enterocolitica presented with acute diarrhoea associated with fever and pharyngitis; chronic or recurrent diarrhoea; or pain in the right iliac fossa associated with mesenteric adenitis. Gastrointestinal symptoms usually resolved spontaneously within two weeks. However, some children were treated successfully with cotrimoxazole.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877859     DOI: 10.5694/j.1326-5377.1985.tb119908.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

1.  Clinical features of patients with novel Yersinia species.

Authors:  Conor G Loftus; Gavin C Harewood; Franklin R Cockerill; Joseph A Murray
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

2.  Unique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible.

Authors:  Juraj Bosák; Lenka Micenková; Martin Vrba; Alena Ševčíková; Daniela Dědičová; Debora Garzetti; David Šmajs
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.